Science & Technology Current Affairs
The Chinese Government approved the world’s first new drug in nearly two decades for the treatment of Alzheimer’s disease named Oligomannate. The drug Oligomannate was given approval on 2nd November 2019 by China’s National Medical Products Administration (NMPA) was developed at Shanghai-based Green Valley Pharmaceuticals. The drug Oligomannate would be released in China by the ..
Category: Science & Technology Current Affairs